Results · Apr-Jun 2026
Genomic Valley Biotech Q1 FY27 results
Sales fell 58% to ₹0.04 crore from ₹0.09 crore in Apr-Jun 2025.
Operating profit fell 40% to ₹0.02 crore, an operating margin of 40.5% (up 12.2 points from a year ago).
Net profit fell 41% to ₹0.01 crore from ₹0.02 crore in Apr-Jun 2025.
Against Jan-Mar 2026: sales +1%, net profit turns positive.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.0 | 0.1 | −58% |
| Operating profit (EBITDA) | 0.0 | 0.0 | −40% |
| Operating margin | 40.5% | 28.3% | +12.2 pts |
| Net profit | 0.0 | 0.0 | −41% |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.